Epilepsy trials in Ireland

2 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  Where

  DO NOT EDIT

  Age

  18 years to 75 years

  People

  333 worldwide

  Run by

  Rapport Therapeutics Inc.

  See details and how to joinNCT07563881 · EU 2025-524847-11-01
• Phase 3Enrolling by invitation
  An Open-label Study of XEN1101 in Epilepsy

  Where

  Dublin 9

  Age

  12 years and over

  People

  880 worldwide

  Run by

  Xenon Pharmaceuticals Inc.

  See details and how to joinNCT05718817 · EU 2022-502282-24-00